Get the latest Science News and Discoveries

Synapse-restoring pill set for human trials as novel schizophrenia treatment

Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic lateral sclerosis (ALS), has now set its sights on using the pill to provide a novel treatment for another debilitating disease: schizophrenia.

None

Get the Android app